Cytomegalovirus Retinitis After Fluocinolone Acetonide (Retisert™) Implant - 21/08/11
Résumé |
Purpose |
To report a case of cytomegalovirus (CMV) retinitis after placement of a fluocinolone acetonide (Retisert™) implant.
Design |
Interventional case report.
Methods |
Retrospective chart review.
Results |
A 65-year-old man with a history of Adamantiades-Behcet disease and bilateral recurrent uveitis that was unresponsive to systemic corticosteroid-sparing immunosuppressive therapy developed clinical evidence of CMV retinitis after receiving his second intravitreal Retisert™ implant in the left eye, while on no systemic immunosuppression. He did not develop CMV retinitis in the right eye despite multiple intraocular and periocular steroid injections. The patient responded well to intravitreal foscarnet followed by placement of an intravitreal ganciclovir implant.
Conclusions |
Ophthalmologists should be aware of the potential risk for development of CMV retinitis after local ocular immunosuppressive therapy.
Le texte complet de cet article est disponible en PDF. The authors indicate no financial support or financial conflict of interest in this study. All authors were involved in design and study; All authors were involved in collection, management, analysis and interpretation of data, and preparation of the data; Involved in collection of data; and involved in management, statistical analysis and interpretation of the data, and preparation of the manuscript. |
Vol 143 - N° 2
P. 334-335 - février 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?